BRIEF published on 04/03/2026 at 07:05, 2 months ago Innate Pharma will participate in the Kempen Life Sciences Conference Biotechnology Conference Innate Pharma Immunothérapies Kempen Life Sciences
BRIEF published on 04/03/2026 at 07:05, 2 months ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
PRESS RELEASE published on 04/03/2026 at 07:00, 2 months ago Inside Information / Other news releases Innate Pharma to participate in the Kempen Life Sciences Conference on April 15-16, 2026, in Amsterdam, Netherlands. The company is developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients Kempen Life Sciences Conference
BRIEF published on 12/11/2025 at 07:05, 5 months 23 days ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
BRIEF published on 12/11/2025 at 07:05, 5 months 23 days ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
PRESS RELEASE published on 12/11/2025 at 07:00, 5 months 23 days ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
BRIEF published on 11/28/2025 at 07:05, 6 months 5 days ago New number of shares and voting rights of Innate Pharma Euronext Paris Share Capital Nasdaq Innate Pharma Shares And Rights
BRIEF published on 11/17/2025 at 07:05, 6 months 16 days ago Innate Pharma to Present at Jefferies Global Healthcare Conference Biotechnology Immunotherapy Innate Pharma Jefferies Conference Antibody Therapeutics
PRESS RELEASE published on 11/17/2025 at 07:00, 6 months 16 days ago Inside Information / Other news releases Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
BRIEF published on 10/14/2025 at 07:05, 7 months 20 days ago Innate Pharma Highlights Lacutamab at Analyst and Investor Event Investors Clinical Trial Innate Pharma Lacutamab Sézary Syndrome
Published on 06/03/2026 at 09:01, 32 minutes ago Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 4 hours 35 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 9 hours 33 minutes ago Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/02/2026 at 22:30, 11 hours 3 minutes ago INEO Announces Effective Date of Share Consolidation
Published on 06/03/2026 at 09:27, 6 minutes ago Bajaj Mobility AG for its 100% subsidiary KTM AG: Senior Executive to strengthen R&D - Christof Lischka appointed Chief Technology and Product Officer of KTM AG
Published on 06/03/2026 at 09:18, 15 minutes ago Homann Holzwerkstoffe publishes its 2025 Sustainability Statement and is already using the revised ESRS
Published on 06/03/2026 at 09:05, 28 minutes ago Dstny Launches Always-On Communications: Business Communications That Never Sleep
Published on 06/03/2026 at 09:00, 33 minutes ago Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 06/03/2026 at 08:45, 48 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 15 hours 30 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 15 hours 51 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 15 hours 53 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day 1 hour ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
